Market research
603368.SHG Guangxi Liuzhou Pharmaceutical Co., Ltd
SHG CNY Healthcare
Latest close
—
—
Loading market data…
Test a moving-average rule with historical data.
Market facts
- Market cap
- 6B
- P/E ratio
- 9.52
- Analyst target
- 19.37
- Dividend yield
- 4.3%
- Beta
- 0.37
Community
Investor discussion
1 comment
Sign in to join the 603368.SHG discussion.
5 years, 5 months ago
Guangxi Liuzhou Pharmaceutical Co., Ltd is currently in a long term downtrend where the price is trading 9.0% below its 200 day moving average.
From a valuation standpoint, the stock is 94.8% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 0.5.
Guangxi Liuzhou Pharmaceutical Co., Ltd's total revenue rose by 4.4% to $4B since the same quarter in the previous year.
Its net income has dropped by 25.1% to $103M since the same quarter in the previous year.
Finally, its free cash flow grew by 20.9% to $1B since the same quarter in the previous year.
Based on the above factors, Guangxi Liuzhou Pharmaceutical Co., Ltd gets an overall score of 3/5.